bio chat
overall cost of the tests
and hence, to make
them affordable for
everyone is the biggest
challenge for us.
Is the cost
effectiveness still
an issue as far as
poorer sections
of society are
concerned? How
are you addressing
the balancing act
between quality
and yet affordable
price?
As a service provider,
affordability to
everyone is one of
our prime focus, but,
it is one of the major
challenges to sustain
in the business in
this industry. I think
government’s new
healthcare policy will
help to bridge that gap.
Being in the healthcare
domain, we cannot
compromise on the
quality, because our
results will change
the lives of many. We
28
BioVoiceNews | July 2017
always maintain it as
per the international
standards and try to
We remain
committed
to bring
the most
advanced
technologies
to India,
validate them
for the Indian
environment
and then
ensure its
availability to
the masses
at a very
affordable
price
make it affordable.
We offer customized
solutions at all levels
of the healthcare
platform be it a super-
specialty hospital,
clinics, day care
centers, wellness &
lifestyle clinics (both
rural and urban).
How do you analyse
the latest trends in
medical diagnostics
in India? Where is
the market heading
to?
The bridge between
innovation globally
and in India is filling
at a very faster pace.
The Indian market is
evolving and maturing
as per the Indian
appetite. Sequencing
is nowadays a major
trend, especially in
high-end diseases. We
are slowly entering
the clinical space
from being only
academic and research
organization centric.
Today, the diagnostics
are more technology-
driven and hence, we
are moving from being
a pure play hardware-
driven business to a
technology-enabled
business. The use of